Phase 1 Study Of Investigational Agent MLN8237 (Alisertib) plus Rituximab +/- Vincristine In Patients (Pts) With Relapsed/Refractory (Rel/Ref) Aggressive B-Cell Lymphomas

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kelly, KR; Persky, DO; Mahadevan, D; Miller, TP; Puvvada, SD; McDonagh, K; Hayslip, J; Park, SI; Ruan, J; Rosen, PJ; Iyer, SP; Stefanovic, A; Zhang, B; Zhou, X; Ullmann, CD; Leonard, EJ; Friedberg, JW

Published Date

  • November 15, 2013

Published In

Volume / Issue

  • 122 / 21

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971